Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deane

Showing results (671-680 of 711) with videos related to

Pageof 72
Sort By:
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Elife|February 11, 2021
The allosteric modulation of complement C5 by knob domain peptidesAlex Macpherson, Maisem Laabei, Zainab Ahdash, et al.
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|October 24, 2018
Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care unitsAlexis P Poole, James Anstey, Rinaldo Bellomo, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled TrialAdam M Deane, Lorraine Little, Rinaldo Bellomo, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in CellsPatrick J Brennan, Rebecca E Saunders, Mary Spanou, et al.
BMJ Open|May 19, 2023
What counts as patient-important upper gastrointestinal bleeding in the ICU? A mixed-methods study protocol of patient and family perspectivesDeborah J Cook, Marilyn Swinton, Karla D Krewulak, et al.
Frontiers in Immunology|January 1, 2021
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune SignaturesJacob D Galson, Sebastian Schaetzle, Rachael J M Bashford-Rogers, et al.
Pageof 72

Showing results (671-680 of 711) with videos related to

Sort By:
Pageof 72
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Elife|February 11, 2021
The allosteric modulation of complement C5 by knob domain peptidesAlex Macpherson, Maisem Laabei, Zainab Ahdash, et al.
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|October 24, 2018
Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care unitsAlexis P Poole, James Anstey, Rinaldo Bellomo, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled TrialAdam M Deane, Lorraine Little, Rinaldo Bellomo, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in CellsPatrick J Brennan, Rebecca E Saunders, Mary Spanou, et al.
BMJ Open|May 19, 2023
What counts as patient-important upper gastrointestinal bleeding in the ICU? A mixed-methods study protocol of patient and family perspectivesDeborah J Cook, Marilyn Swinton, Karla D Krewulak, et al.
Frontiers in Immunology|January 1, 2021
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune SignaturesJacob D Galson, Sebastian Schaetzle, Rachael J M Bashford-Rogers, et al.
Pageof 72